Brain tumors, multiple myeloma, and certain types of lymphoma may be treated with carmustine. This prescription chemotherapy drug works by preventing cancer cells from growing and multiplying. It is given intravenously by a healthcare provider. Your dosage will depend on your height, weight, and various other factors. Side effects are common and may include nausea, vomiting, and low blood cell counts.
What Is Carmustine?Carmustine (BiCNU®) is a prescription chemotherapy medication. It is approved to treat certain types of cancer, including:
- Brain tumors
- Multiple myeloma (a cancer of the bone marrow)
- Hodgkin's lymphoma
- Non-Hodgkin's lymphoma.
Carmustine belongs to a group of medicines known as alkylating agents. There are several different types of alkylating agents. Carmustine is in a class of alkylating agents known as nitrosoureas.
This medicine contains the active drug carmustine. Carmustine is sometimes referred to as BCNU, because its chemical name is bis-chloroethylnitrosourea.
Carmustine is also available as an implant, Gliadel® (carmustine implant). The implant is approved to treat certain types of brain tumors and is surgically inserted into the brain after a brain tumor is removed.
(Click What Is Carmustine Used For? for more information on this topic, including possible off-label uses.)